Abstract
IDARS is an acronym for the International Drug Abuse Research Society. Apart from our scientific and educational purposes, we communicate information to the general and scientific community about substance abuse and addiction science and treatment potential. Members of IDARS are research scientists and clinicians from around the world, with scheduled meetings across the globe. IDARS is developing a vibrant and exciting international mechanism not only for scientific interactions in the domain of addiction between countries but also ultimately as a resource for informing public policy across nations. Nonetheless, a lot more research needs to be done to better understand the neurobiological basis of drug addiction – A challenge for IDARS scientists.
Keywords: International Drug Abuse Research Society, IDARS, addiction, alcohol, marijuana, psychostimulants, Addiciton, CNR1, CNR2, Cannabinoids Receptors (CBRs), Obesity, NMDAR
Current Neuropharmacology
Title: Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists
Volume: 9 Issue: 1
Author(s): S. F. Ali, E. S. Onaivi, P. R. Dodd, J. L. Cadet, S. Schenk, M. J. Kuhar and G. F. Koob
Affiliation:
Keywords: International Drug Abuse Research Society, IDARS, addiction, alcohol, marijuana, psychostimulants, Addiciton, CNR1, CNR2, Cannabinoids Receptors (CBRs), Obesity, NMDAR
Abstract: IDARS is an acronym for the International Drug Abuse Research Society. Apart from our scientific and educational purposes, we communicate information to the general and scientific community about substance abuse and addiction science and treatment potential. Members of IDARS are research scientists and clinicians from around the world, with scheduled meetings across the globe. IDARS is developing a vibrant and exciting international mechanism not only for scientific interactions in the domain of addiction between countries but also ultimately as a resource for informing public policy across nations. Nonetheless, a lot more research needs to be done to better understand the neurobiological basis of drug addiction – A challenge for IDARS scientists.
Export Options
About this article
Cite this article as:
F. Ali S., S. Onaivi E., R. Dodd P., L. Cadet J., Schenk S., J. Kuhar M. and F. Koob G., Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists, Current Neuropharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157015911795017245
DOI https://dx.doi.org/10.2174/157015911795017245 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry
Current Neuropharmacology Effects of Gene and Plasma Tau on Cognitive Impairment in Rural Chinese Population
Current Alzheimer Research The Mechanisms and Quantification of the Selective Permeability in Transport Across Biological Barriers: the Example of Kyotorphin
Mini-Reviews in Medicinal Chemistry Phenolic Compounds from Plants as Nitric Oxide Production Inhibitors
Current Medicinal Chemistry Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer’s Disease: A Phase 2, Open-Label Extension Study
Current Alzheimer Research Locus (Coeruleus) Minoris Resistentiae in Pathogenesis of Alzheimer’s Disease
Current Alzheimer Research Serum Fragments of Tau for the Differential Diagnosis of Alzheimer's Disease
Current Alzheimer Research Doxorubicin: The Good, the Bad and the Ugly Effect
Current Medicinal Chemistry Diabetic Retinopathy, Superoxide Damage and Antioxidants
Current Pharmaceutical Biotechnology Editorial (Hot Topic: The First Theme Issue on PPARs for Brain Disorders)
Current Drug Targets The Pulse of Drug Development for Alzheimers Disease
Reviews on Recent Clinical Trials Pharmacotherapy of Borderline Personality Disorder: A Systematic Review
Current Medicinal Chemistry Targeting Matrix Metalloproteinases in Acute Inflammatory Shock Syndromes
Combinatorial Chemistry & High Throughput Screening FMRI of the Emotions: Towards an Improved Understanding of Amygdala Function
Current Medical Imaging Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease
Current Alzheimer Research Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review
Drug Delivery Letters Hepatocarcinogenesis and Ceramide/Cholesterol Metabolism
Anti-Cancer Agents in Medicinal Chemistry Physiology and Pathophysiology of Na+/H+ Exchange Isoform 1 in the Central Nervous System
Current Neurovascular Research Renovascular Hypertension: Lesion Detection, Patient Selection, Treatment Options and Results
Current Hypertension Reviews